Camtek Ltd.
NASDAQ:CAMTSemiconductors
-$4.10 today
- Market cap
- $4.60B
- Beta
- 1.56
- P/E (TTM)
- 171.8
- EPS (TTM)
- $1.04
Volume 0.72M
Average 0.46M
CAMT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Camtek Ltd.NASDAQ: CAMT
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development growth accelerates
Q2 FY2026 research & development of $16.68M rose 45.4% year over year, ahead of the +37.0% change in trailing-twelve-month research & development. Sequentially, it rose 16.5% from the prior quarter. Over 3 fiscal years it compounded at +18.8% a year.
Context
- Research & development amounted to 9.7% of revenue in FY2025, up 0.8 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +45.4% holds above the trailing-twelve-month pace of +37.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 48.35M USD
- Year-over-year change
- +26.3%
- 4-year CAGR
- +19.8%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 48.35M | +26.3% |
| FY2024 | 2024-12-31 | 38.29M | +21.7% |
| FY2023 | 2023-12-31 | 31.47M | +9.0% |
| FY2022 | 2022-12-31 | 28.86M | +22.9% |
| FY2021 | 2021-12-31 | 23.47M | — |
Research & Development vs competitors
How CAMT compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +37.0% is the highest of 11, against a peer median of +9.4%.
- Research & development amounts to 11.3% of revenue for CAMT, versus a peer median of 12.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | €4.9B EUR | +7.6% | +15.2% | 12.4% | |
| LTM Jun 2026 | $1.53B USD | +12.6% | +5.7% | 11.3% | |
| LTM Jun 2026 | $559.87M USD | +16.1% | +4.6% | 12.5% | |
| LTM Sep 2026 | $155.21M USD | +18.7% | +5.6% | 11.8% | |
| LTM Sep 2026 | $128.86M USD | +7.4% | +4.9% | 17.7% | |
| LTM Sep 2026 | $121.79M USD | +5.2% | +2.0% | 12.4% | |
| LTM Jun 2026 | $97.2M USD | +11.1% | -0.1% | 18.6% | |
| LTM Jun 2026 | $57.52M USD | +37.0% | +18.8% | 11.3% | |
| LTM Mar 2026 | $22.74M USD | -3.3% | +5.7% | 2.4% | |
| LTM May 2026 | $12.63M USD | +20.7% | +21.0% | 24.8% | |
| LTM Mar 2026 | $9.58M USD | +6.3% | +7.8% | 7.9% | |
| Peer median (excluding CAMT) | — | +9.4% | +5.7% | 12.4% | |
Competitors are the stored peer set for CAMT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 269.66M | 320.91M | 315.38M | 429.23M | 496.07M |
| Cost of Revenue | 132.32M | 161.05M | 167.74M | 219.28M | 245.76M |
| Gross Profit | 137.34M | 159.86M | 147.63M | 209.95M | 250.32M |
| Gross Margin | 50.9% | 49.8% | 46.8% | 48.9% | 50.5% |
| Research & Development | 23.47M | 28.86M | 31.47M | 38.29M | 48.35M |
| Selling, General & Admin | 42.97M | 49.5M | 50.75M | 63.6M | 73.77M |
| Operating Expenses | 66.45M | 78.36M | 82.22M | 101.88M | 122.11M |
| Depreciation & Amortization | 2.81M | 5.36M | 5.78M | 10.67M | 11.78M |
| EBITDA | 75.18M | 94.64M | 94.51M | 143M | 64.11M |
| EBITDA Margin | 27.9% | 29.5% | 30.0% | 33.3% | 12.9% |
| Operating Income | 70.9M | 81.5M | 65.41M | 108.07M | 128.2M |
| Operating Margin | 26.3% | 25.4% | 20.7% | 25.2% | 25.8% |
| Interest Income | 1.41M | 8.65M | 24.05M | 24.84M | 25.06M |
| Interest Expense | 436K | 1.09M | 1.76M | 1.09M | 0 |
| Other Income / Expenses | 1.03M | 6.69M | 22.22M | 23.17M | (75.87M) |
| Income Before Tax | 71.93M | 88.19M | 87.63M | 131.24M | 52.34M |
| Pre-Tax Margin | 26.7% | 27.5% | 27.8% | 30.6% | 10.5% |
| Income Tax Expense | 11.65M | 8.24M | 9M | 12.72M | 1.61M |
| Net Income | 60.28M | 79.95M | 78.63M | 118.52M | 50.72M |
| Net Margin | 22.4% | 24.9% | 24.9% | 27.6% | 10.2% |
| EPS (Basic) | 1.38 | 1.81 | 1.76 | 2.62 | 1.11 |
| EPS (Diluted) | 1.34 | 1.66 | 1.61 | 2.42 | 1.04 |
| Weighted Avg Shares | 43.64M | 44.16M | 44.73M | 45.28M | 45.7M |
| Weighted Avg Shares (Diluted) | 45.04M | 48.23M | 48.86M | 49.37M | 49.97M |
Camtek Ltd.
NASDAQ:CAMT
Intrinsic Alpha fair value
Locked
Current Price
$98.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.